alexa Cardiovascular Safety Of The Glucose Lowering Therapies
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

16th World Cardiology Congress
December 08-10, 2016 Dubai, UAE

Sameh Ahmed Salama
Cairo University, Egypt
ScientificTracks Abstracts: J Clin Exp Cardiolog
DOI: 10.4172/2155-9880.C1.062
Abstract
Cardiovascular Disease (CVD) and diabetes are among the leading global and regional causes of death between 1990 and 2016. CVD deaths increased by 25%. In a recent comparative assessment of the global burden of metabolic risk factors for CVD, 60% of worldwide CVD deaths in year 2010 was attributable to four modifiable cardiometabolic risk factors: high BP, blood glucose, BMI, and serum cholesterol. Heart failure is twice as common in diabetic men and five times as common in diabetic women compared to non-diabetics and mortality rates are about twice that of non-diabetic population. The clinical spectrum of cardiovascular diseases in diabetes involves coronary artery disease, heart failure, serious arrythmias and sudden cardiac death, peripheral vascular disease, cerebrovascular disease and stroke. Higher glucose levels predicts higher CV risk, each 1% increase in HBA1c leads to 15% increase in the risk of heart failure. It is conclusively established that the microvascular complications of diabetes (retinopathy, nephropathy and neuropathy) are directly related to the severity and duration of hyperglycaemia, as reflected by the HbA1c. However, macrovascular complications are the primary cause of mortality, with myocardial infarction and stroke accounting for 80% of all deaths in diabetic patients. Therefore, when selecting medications to normalize glucose levels in diabetic patients, it is important that the agent should not aggravate, and ideally even improve, Cardiovascular Risk Factors (CVRFs) and reduce cardiovascular morbidity and mortality. In this presentation, we will review the effect of oral glucose-lowering drugs (metformin, sulfonylureas, meglitinides, thiazolidinediones, DPP4 inhibitors, SGLT2 inhibitors and α-glucosidase inhibitors) on established CVRFs and long-term studies of cardiovascular outcomes.
Biography

Sameh Ahmed Salama is currently a Professor of Cardiology at Cairo University. He completed his Doctorate degree in Cardiovasculr Medicine at Cairo University, after completing his training on “Coronary interventions and intravascular imaging in the states” in the period from 1997 to 1999. He is a Fellow of Society of Coronary Angiography and Interventions (SCAI). He is a member of the Egyptian and European Societies of Cardiology as well as the Egyptian Hypertension Society. He is also a Member of the Executive Board of the Egyptian Association of Vascular Biology & Atherosclerosis. His main interest is in “Coronary interventions and intravascular imaging”. He has numerous publications in reputed journals. He is currently serving as an Editorial Board Member in three international journals. He participated, as a Prinicipal Investigator in many international cardiovascular trials.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords